Genetic Testing Market 2024-2028: Key Insights and Trends

The Global genetic testing market is expected to grow significantly, with a projected increase of USD 8.89 billion at a CAGR of 14.02% from 2023 to 2028. This growth is driven by factors such as the rising prevalence of genetic diseases, advancements in technology, and the approval of new testing products. As genetic testing becomes more affordable and accessible, its adoption in healthcare continues to expand.

For more details about the industry, get the PDF sample report for free

Market Segmentation

The genetic testing market is categorized into the following segments:

• Product

  • Equipment
  • Consumables

• Technology

  • Molecular Testing
  • Cytogenetic Testing
  • Biochemical Testing

• Geography

  • North America
    • US
  • Europe
    • Germany
    • UK
    • France
  • Asia
    • Japan
  • Rest of World (ROW)

Regional Market Trends

• North America: The North American region is forecast to contribute 39% to the global market growth during the forecast period. Factors such as increased concerns over early disease diagnosis, rising commercial approvals for advanced testing products, and the expanding use of pharmacogenomic testing drive the market here. North America also leads in cancer genetic testing, with a focus on diseases like breast, ovarian, and prostate cancer.

• Europe: Europe, particularly countries like Germany, the UK, and France, is experiencing steady growth due to advancements in genetic technologies and increasing healthcare expenditure.

• Asia: Japan is at the forefront of adopting genetic testing technologies, with a rising demand for personalized medicine and cancer diagnostics.

Market Drivers

• The rising prevalence of genetic diseases, such as Alzheimer’s, Parkinson’s, Thalassemia, Down's syndrome, Cystic fibrosis, and various types of cancer, is a key driver for market growth.
• Technological advancements in DNA testing, such as next-generation sequencing (NGS), enable the detection of genetic mutations and inherited diseases more efficiently.
• There is a growing need for genetic testing registries to improve awareness and accessibility.

Market Trends

• Advancements in Next-Generation Sequencing: Innovations in next-generation sequencing technologies are revolutionizing the market by allowing for comprehensive DNA analysis and improving diagnostic capabilities for conditions like Thalassemia, Down’s syndrome, and cancer.
• Telemedicine Integration: The increasing use of telemedicine is making genetic testing more accessible, expanding market reach and improving patient care.

Market Challenges

• Varying Regulations: Regulatory hurdles remain a challenge as genetic testing and research are subject to stringent regulations by bodies like the US FDA, WHO, and ISO. These regulations impact the speed and cost of bringing new genetic tests to market.
• Awareness and Understanding: Despite technological advancements, there remains a lack of awareness and understanding about the benefits of genetic testing, which could hinder broader adoption.

Get more details by ordering the complete report

Key Players

The genetic testing market is competitive, with key players such as:

• Illumina Inc.
• F. Hoffmann La Roche Ltd.
• Abbott Laboratories Inc.
• Agilent Technologies Inc.
• ARUP Laboratories
• Asper Biogene
• ATS GENETECH PVT. LTD.
• Bio Rad Laboratories Inc.
• bioMerieux SA
• CENTOGENE NV
• Color Health Inc.
• Danaher Corp.
• Genea Ltd.
• Invitae Corp.
• MedGenome Labs Ltd.
• Myriad Genetics Inc.
• QIAGEN NV
• Quest Diagnostics Inc.
• Siemens Healthineers AG
• The Cooper Companies Inc.